Mariella G. Filbin
Affiliations: | Dana-Farber Cancer Institute, Boston, MA, United States |
Google:
"Mariella Filbin"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ausejo-Mauleon I, Labiano S, de la Nava D, et al. (2023) TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell |
| Bruschi M, Midjek L, Ajlil Y, et al. (2023) Diffuse Midline Glioma Invasion and Metastasis Rely on Cell-autonomous Signaling. Neuro-Oncology |
| Venneti S, Kawakibi AR, Ji S, et al. (2023) Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways. Cancer Discovery |
| Okonechnikov K, Joshi P, Sepp M, et al. (2023) Mapping pediatric brain tumors to their origins in the developing cerebellum. Neuro-Oncology |
| Pun M, Pratt D, Nano PR, et al. (2023) Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways. Acta Neuropathologica Communications. 11: 25 |
| Savchuk S, Gentry K, Wang W, et al. (2023) Neuronal-Activity Dependent Mechanisms of Small Cell Lung Cancer Progression. Biorxiv : the Preprint Server For Biology |
| Gonzalez Castro LN, Liu I, Filbin M. (2023) Erratum to: Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods. Neuro-Oncology. 25: 211 |
| Gonzalez Castro LN, Liu I, Filbin M. (2023) Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods. Neuro-Oncology. 25: 234-247 |
| Panditharatna E, G Marques J, Wang T, et al. (2022) BAF complex maintains glioma stem cells in pediatric H3K27M-glioma. Cancer Discovery |
| Bernstock JD, Hoffman SE, Kappel AD, et al. (2022) Immunotherapy approaches for the treatment of diffuse midline gliomas. Oncoimmunology. 11: 2124058 |